Loading clinical trials...
Loading clinical trials...
Personalized 1st-line Treatment of Patients With NSCLC: is Timely Analysis of EGFR-mutation Status Feasible in a Routine Practice Setting in Antwerp.
Conditions
Locations
11
Belgium
Universitair Ziekenhuis Antwerpen
Edegem, Antwerpen, Belgium
AZ Monica
Antwerp, Belgium
GZA Sint Vincentius - Sint Augustinus
Antwerp, Belgium
ZNA Middelheim - ZNA STER - ZNA Jan Palfijn
Antwerp, Belgium
AZ St Jozef Bornem en Willebroek
Bornem, Belgium
AZ Klina
Brasschaat, Belgium
Start Date
November 1, 2010
Primary Completion Date
September 1, 2011
Completion Date
September 1, 2011
Last Updated
January 18, 2012
NCT06066138
NCT07485114
NCT05098132
NCT06284317
NCT06731413
NCT06687369
Lead Sponsor
University Hospital, Antwerp
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions